Acrivon Therapeutics ACRV
NASDAQ ACRV
$1.73 -0.03 (-1.70%)
At close: Oct 23, 2026 · 4:00 PM EDT

Acrivon Therapeutics (ACRV) Sale and Maturity of Investments (2022 - 2026)

Updated

Analysis

Acrivon Therapeutics (ACRV) Sale and Maturity of Investments (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Acrivon Therapeutics 74.13 Mn -361.41 Mn - 25.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 25.00 Mn
Mar 31, 2026 30.00 Mn
Dec 31, 2025 35.00 Mn
Sep 30, 2025 40.00 Mn
Jun 30, 2025 35.00 Mn
Mar 31, 2025 39.50 Mn
Dec 31, 2024 50.00 Mn
Sep 30, 2024 22.00 Mn
Jun 30, 2024 46.93 Mn
Mar 31, 2024 35.00 Mn
Dec 31, 2023 38.27 Mn
Sep 30, 2023 24.50 Mn
Jun 30, 2023 19.45 Mn
Mar 31, 2023 26.32 Mn
Dec 31, 2022 6.00 Mn
API Access

Acrivon Therapeutics Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=ACRV&period=max&api_key=YOUR_API_KEY